These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 38213654)

  • 1. Implications of Cell Adhesion Molecules in Autism Spectrum Disorder Pathogenesis.
    Sindi IA
    J Microsc Ultrastruct; 2023; 11(4):199-205. PubMed ID: 38213654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroligin-3: A Circuit-Specific Synapse Organizer That Shapes Normal Function and Autism Spectrum Disorder-Associated Dysfunction.
    Uchigashima M; Cheung A; Futai K
    Front Mol Neurosci; 2021; 14():749164. PubMed ID: 34690695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using structural analysis to clarify the impact of single nucleotide variants in neurexin/neuroligin revealed in clinical genomic sequencing.
    Xue K; Hu Y; Gu S; Wang C; Kong R; Xie W; Li J
    J Biomol Struct Dyn; 2022 Oct; 40(17):8085-8099. PubMed ID: 33818307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHANK1 and autism spectrum disorders.
    Gong X; Wang H
    Sci China Life Sci; 2015 Oct; 58(10):985-90. PubMed ID: 26335738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distortion of the normal function of synaptic cell adhesion molecules by genetic variants as a risk for autism spectrum disorders.
    Baig DN; Yanagawa T; Tabuchi K
    Brain Res Bull; 2017 Mar; 129():82-90. PubMed ID: 27743928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptopathology Involved in Autism Spectrum Disorder.
    Guang S; Pang N; Deng X; Yang L; He F; Wu L; Chen C; Yin F; Peng J
    Front Cell Neurosci; 2018; 12():470. PubMed ID: 30627085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroligins and the synaptic pathway in Autism Spectrum Disorder.
    Trobiani L; Meringolo M; Diamanti T; Bourne Y; Marchot P; Martella G; Dini L; Pisani A; De Jaco A; Bonsi P
    Neurosci Biobehav Rev; 2020 Dec; 119():37-51. PubMed ID: 32991906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in neurexin studies and the emerging role of neurexin-2 in autism spectrum disorder.
    Khoja S; Haile MT; Chen LY
    Front Mol Neurosci; 2023; 16():1125087. PubMed ID: 36923655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of rare neuroligin 1 variants found in autism.
    Nakanishi M; Nomura J; Ji X; Tamada K; Arai T; Takahashi E; Bućan M; Takumi T
    PLoS Genet; 2017 Aug; 13(8):e1006940. PubMed ID: 28841651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functions of synapse adhesion molecules neurexin/neuroligins and neurodevelopmental disorders.
    Cao X; Tabuchi K
    Neurosci Res; 2017 Mar; 116():3-9. PubMed ID: 27664583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autism Spectrum Disorder/Intellectual Disability-Associated Mutations in Trio Disrupt Neuroligin 1-Mediated Synaptogenesis.
    Tian C; Paskus JD; Fingleton E; Roche KW; Herring BE
    J Neurosci; 2021 Sep; 41(37):7768-7778. PubMed ID: 34353896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurexin gene family variants as risk factors for autism spectrum disorder.
    Wang J; Gong J; Li L; Chen Y; Liu L; Gu H; Luo X; Hou F; Zhang J; Song R
    Autism Res; 2018 Jan; 11(1):37-43. PubMed ID: 29045040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling.
    Arons MH; Thynne CJ; Grabrucker AM; Li D; Schoen M; Cheyne JE; Boeckers TM; Montgomery JM; Garner CC
    J Neurosci; 2012 Oct; 32(43):14966-78. PubMed ID: 23100419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between NLGN3, NLGN4, SHANK2 and SHANK3 gene variants and autism spectrum disorder in a Chinese population.
    Liu Y; Du Y; Liu W; Yang C; Liu Y; Wang H; Gong X
    PLoS One; 2013; 8(2):e56639. PubMed ID: 23468870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Autism-Associated Mutation Impairs Neuroligin-4 Glycosylation and Enhances Excitatory Synaptic Transmission in Human Neurons.
    Cast TP; Boesch DJ; Smyth K; Shaw AE; Ghebrial M; Chanda S
    J Neurosci; 2021 Jan; 41(3):392-407. PubMed ID: 33268543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Shank3 deficiency and paresthesia in autism spectrum disorder: A brief review.
    Huang M; Qi Q; Xu T
    Front Mol Neurosci; 2023; 16():1128974. PubMed ID: 36846568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational control and autism-like behaviors.
    Gkogkas CG; Sonenberg N
    Cell Logist; 2013 Jan; 3(1):e24551. PubMed ID: 24516777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroligins and Neurodevelopmental Disorders: X-Linked Genetics.
    Nguyen TA; Lehr AW; Roche KW
    Front Synaptic Neurosci; 2020; 12():33. PubMed ID: 32848696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychopathology of Autism Spectrum Disorder: Complex Interplay of Genetic, Epigenetic, and Environmental Factors.
    Bhandari R; Paliwal JK; Kuhad A
    Adv Neurobiol; 2020; 24():97-141. PubMed ID: 32006358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroligins, synapse balance and neuropsychiatric disorders.
    Maćkowiak M; Mordalska P; Wędzony K
    Pharmacol Rep; 2014 Oct; 66(5):830-5. PubMed ID: 25149987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.